Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)

Clodagh Towns, Madeleine Richer, Simona Jasaityte, Eleanor J. Stafford, Julie Joubert, Tarek Antar, Alejandro Martinez-Carrasco, Mary B. Makarious, Bradford Casey, Dan Vitale, Kristin Levine, Hampton Leonard, Caroline B. Pantazis, Laurel A. Screven, Dena G. Hernandez, Claire E. Wegel, Justin Solle, Mike A. Nalls, Cornelis Blauwendraat, Andrew B. Singleton, Manuela M. X. Tan, Hirotaka Iwaki, Huw R. Morris, the Global Parkinson’s Genetics Program (GP2)
doi: https://doi.org/10.1101/2022.11.25.22282764

Article Information

doi 
https://doi.org/10.1101/2022.11.25.22282764
History 
  • May 15, 2023.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Clodagh Towns1,
  2. Madeleine Richer1,
  3. Simona Jasaityte1,
  4. Eleanor J. Stafford1,
  5. Julie Joubert1,
  6. Tarek Antar2,
  7. Alejandro Martinez-Carrasco1,
  8. Mary B. Makarious1,2,
  9. Bradford Casey3,
  10. Dan Vitale4,5,
  11. Kristin Levine4,5,
  12. Hampton Leonard2,4,5,
  13. Caroline B. Pantazis4,
  14. Laurel A. Screven4,
  15. Dena G. Hernandez2,
  16. Claire E. Wegel6,
  17. Justin Solle3,
  18. Mike A. Nalls2,4,5,
  19. Cornelis Blauwendraat4,7,
  20. Andrew B. Singleton2,4,
  21. Manuela M. X. Tan8,
  22. Hirotaka Iwaki2,4,5,
  23. Huw R. Morris1,*,
  24. the Global Parkinson’s Genetics Program (GP2)
  1. 1Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK
  2. 2Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
  3. 3Department of Clinical Research, Michael J. Fox Foundation for Parkinson’s Research, New York City, NY, USA
  4. 4Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
  5. 5Data Tecnica International, Washington, DC, USA
  6. 6Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA
  7. 7Integrative Genomics Unit, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
  8. 8Department of Neurology, Oslo University Hospital, Oslo, Norway
  1. ↵*Corresponding author: Professor Huw R Morris, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, h.morris{at}ucl.ac.uk.
Back to top
Posted May 15, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
Clodagh Towns, Madeleine Richer, Simona Jasaityte, Eleanor J. Stafford, Julie Joubert, Tarek Antar, Alejandro Martinez-Carrasco, Mary B. Makarious, Bradford Casey, Dan Vitale, Kristin Levine, Hampton Leonard, Caroline B. Pantazis, Laurel A. Screven, Dena G. Hernandez, Claire E. Wegel, Justin Solle, Mike A. Nalls, Cornelis Blauwendraat, Andrew B. Singleton, Manuela M. X. Tan, Hirotaka Iwaki, Huw R. Morris, the Global Parkinson’s Genetics Program (GP2)
medRxiv 2022.11.25.22282764; doi: https://doi.org/10.1101/2022.11.25.22282764
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area